Research aim
Our research is focused on the elucidation of the pathogenesis of Inflammatory bowel diseases (IBD), personalized medicine and on a severe complication of IBD: colitis-associated colorectal carcinoma.Research aim
Understand the immune mechanisms that underly cancer and inflammatory disease, to impact diagnosis and therapeutic strategies in patients.Research aim
Our mission is to comprehensively understand, monitor, and target immune-mediated inflammatory diseases such as IBD, AD and systemic autoimmune diseases. We aim to unravel (tissue) immune dysregulation and induce long-lasting disease modification.Research aim
To address unmet medical needs by detecting novel primary immunodeficiency, and improving clinical practice by optimizing diagnosis, prognosis and treatment of disease.2021: CuCo fellow: strategic alliance consortium Structures of Strength
2020: Member Utrecht Young Academy
2017: Junior member of CancerGenomiCs.nl
2012: Marie Curie International Outgoing Fellowship